WP
BIOA

Woodline Partners’s BioAge Labs BIOA Stock Holding History

Woodline Partners’s Portfolio BIOA Stock Details BIOA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-31,565
Closed -$418K – 1165
2025
Q4 		$418K Hold
31,565
– – ﹤0.01% 918
2025
Q3 		$186K Hold
31,565
– – ﹤0.01% 864
2025
Q2 		$130K Hold
31,565
– – ﹤0.01% 907
2025
Q1 		$119K Sell
31,565
-56,803
-64% -$263K ﹤0.01% 886
2024
Q4 		$512K Sell
88,368
-36,582
-29% -$631K ﹤0.01% 833
2024
Q3 		$2.6M Buy
+124,950
New +$2.5M 0.02% 448

Other funds holding BIOA

ACM
AH Capital Management Menlo Park, California $1.29B AUM 26.81% 1-Year Est. Return
CAM
Cormorant Asset Management Boston, Massachusetts $1.99B AUM 737.95% 1-Year Est. Return
SI
Sofinnova Investments Menlo Park, California $2.63B AUM 117.41% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
OCA
Octagon Capital Advisors New York $904M AUM 737.04% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Balyasny Asset Management
Balyasny Asset Management Chicago, Illinois $77.1B AUM 42.89% 1-Year Est. Return
B
Braidwell Stamford, Connecticut $3B AUM 46.72% 1-Year Est. Return

Woodline Partners's BIOA Position: Q1 2026 in Review

Woodline Partners sold out of BioAge Labs (BIOA) in Q1 2026, closing a stake of 31,565 shares — an estimated $418K sold.

Woodline Partners first reported a position in BIOA in Q3 2024 and held it in 6 quarters. The position peaked at $2.6M in Q3 2024. 144 funds tracked by Wall St. Rank hold BIOA as of Q1 2026.

  • Woodline Partners reported no remaining BioAge Labs position as of Q1 2026 after selling out during the quarter.
  • Woodline Partners sold 31,565 BioAge Labs shares in Q1 2026, an estimated $418K.
  • Woodline Partners first reported a position in BioAge Labs in Q3 2024 and held it in 6 quarters.
  • Woodline Partners's BioAge Labs position peaked at $2.6M in Q3 2024.
  • 144 funds tracked by Wall St. Rank held BioAge Labs as of Q1 2026.

Based on Woodline Partners's 13F filing for Q1 2026, filed 15 May 2026.